In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital
The emergence of multidrug-resistant Gram negative bacteria has given rise to significant therapeutic challenges. These pathogens may have developed resistance to tigecycline, which is an alternative antibiotic used empirically in the treatment of serious infections.The objectives of this study were...
Main Authors: | Z. Elnasser, R. Elsamarneh, H. Obeidat, Z. Amarin, S. Jaradat, N. Kaplan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Journal of Infection and Public Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034120307693 |
Similar Items
-
Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
by: Anna Giammanco, et al.
Published: (2017-02-01) -
Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
by: Stefania Stefani, et al.
Published: (2016-11-01) -
The Tigecycline Evaluation and Surveillance Trial; assessment of the activity of tigecycline and other selected antibiotics against Gram-positive and Gram-negative pathogens from France collected between 2004 and 2016
by: Jean-Winoc Decousser, et al.
Published: (2018-05-01) -
Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units
by: Xiang-rong Bai, et al.
Published: (2023-11-01) -
Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial
by: Zhijie Zhang, et al.
Published: (2018-12-01)